Prolonged QT Syndrome, Torsades

Key Points

Etiology
Drugs
  • Complete list at www.QTDrugs.org
  • Class Ia antidysrhythmics—quinidine, procainamide, disopyramide
  • Class III antidysrhythmics—sotalol, ibutilide, amiodarone
  • Antibiotics—erythromycin, pentamidine, chloroquine, trimethoprim–sulfamethoxazole
  • Antifungal agents—ketoconazole, itraconazole
  • Psychotropic drugs—phenothiazines, haloperidol, risperidone, STCAs
  • Cisapride
  • Antihistamines
  • Organophosphates
  • Narcotics—methadone
Electrolyte abnormalities
  • Hypokalemia
  • Hypomagnesemia
  • Hypocalcemia
Cardiac
  • Bradyarrhythmias
  • Arteriovenous block
  • Mitral valve prolapse
  • Myocarditis
  • Myocardial ischemia
CNS
  • Subarachnoid hemorrhage
  • Stroke
  • Congenital (idiopathic)
Other
  • Protein-sparing fasting
  • Anorexia nervosa
  • Hypothyroidism
  • Hypothermia
Management

 

  • Stable patients with prolonged QT transported without intervention
  • Cardioversion for unstable patients with confirmed torsades de pointes
  • Magnesium sulfate for stable patients with evidence of torsades de pointes

ED TREATMENT/PROCEDURES

  • Magnesium sulfate followed by pacing for torsades de pointes.
    • Magnesium sulfate: 2 g (peds: 25–50 mg/kg) IV bolus over 2–3 min followed by IV infusion at 2–4 mg/min

  • Potassium to serum levels of 4.5–5 mEq/L
  • Temporary transvenous cardiac pacing (rates from 100–120 beats/min) for recurrences of torsades de pointes refractory to magnesium sulfate therapy (shortens QTc)
  • IV isoproterenol for refractory cases or hemodynamically unstable patients with acquired long QT (ineffective in congenital cases) who do not respond to transvenous pacing
      • Isoproterenol: 1 μg/min (peds: 0.05–0.1 μg/kg/ min) IV continuous infusion, titrate for effect, up to 10 μg/min

  • Remove any offending medications and correct metabolic derangements.
  • Consult with cardiology in those with symptomatic long QT regarding use of β-blockers at maximum doses.
    • Propranolol: 2–3 mg/kg/d (peds: 2–3 mg/kg/d) PO (in consultation with cardiology)
  • Pacemaker or defibrillator placement with or without cervicothoracic stellectomy (to reduce adrenergic stimulation) may be required in high-risk patients.
  • β-Blockers prevent 70% of cardiac events in congenital cases.
Critical Actions

▢ EKG ordered, look for prolonged QT syndrome
▢ Recognition of torsades after decompensation
▢ Resuscitation per pediatric advanced life support (PALS) guidelines
▢ Cardiology consultation

Discover more from ER Dispo

Subscribe now to keep reading and get access to the full archive.

Continue reading